![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Lonza Reports Fall in First-Half Profits8:19 AM MDT | July 25, 2012 | Deepti Ramesh Lonza recorded a 3.1% fall in first-half profits compared with the year-ago period, to SF94 million ($94.5 million). First-half sales increased, however, by 64.6%, to SF1.96 billion, mainly due to the acquisition of biocides maker Arch Chemicals (Norwalk, CT), which was completed last October, for $1.4 billion, Lonza says. EBIT for the first half increased by 23.5%, to SF168 million Earlier this year, Lonza fired CEO Stefan Borgas following a series of weak financial results. Richard Ridinger was appointed as the new CEO, starting May 1. The new CEO says he has... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|